Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study
Zeitschrift für Gastroenterologie · 01.01.2024 · 62 (01) · 37-42
DOI: 10.1055/a-2207-5519 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.01.2024. Verfasst von Christoph Schramm und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Transplantational Medicine, University Hospital Essen, and Faculty of Medicine, University of Duisburg…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Cholangitis, Sclerosing, Gallbladder Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
Patients with primary sclerosing cholangitis (PSC) carry increased risks for malignancy, among which cholangiocarcinoma (CCA) is the most frequent. We aimed to characterise a cohort of patients with PSC and intrahepatic CCA (iCCA) and to compare this cohort with CCA in different localisations.
Methods
We performed a retrospective analysis of our medical database from 01.01.2007 to 30.06.2023 and differentiated CCA according to its localisation within the biliary tract into iCCA, perihilar CCA (pCCA), distal CCA (dCCA), and gallbladder carcinoma (GBC).
Results
We identified 8 (28%) patients with iCCA, 14 (48%) patients with pCCA, 6 (21%) patients with GBC, and 1 (3%) patient with dCCA without significant differences in gender distribution and mean age. Mean time between diagnosis of PSC and CCA was 158±84 months for iCCA, 93±94 months for pCCA, and 77±69 months for GBC (p=0.230). At the time of CCA diagnosis, advanced-stage disease was present in 6 (75%) patients with iCCA, 13 (93%) patients with pCCA, and 2 (40%) patients with GBC (p=0.050). Only 5 (63%) patients with iCCA received curatively intended surgery, of whom 4 (80%) patients developed recurrence after a mean time of 38±31 months. Mean survival time in patients with iCCA (35±33 months) lay between patients with pCCA (14±8 months) and patients with GBC (57±58 months), but the difference was not statistically significant (p=0.131).
Conclusion
Patients with PSC and iCCA showed an advanced tumour stage at diagnosis and limited long-time survival, which was classified between pCCA with worse prognosis and GBC with better prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology and Transplantational Medicine, University Hospital Essen, and Faculty of Medicine, University of Duisburg-Essen, Essen, Germany, Essen, Germany.
- Department of General, Visceral and Transplant Surgery, University Hospital Essen, and Faculty of Medicine, University of Duisburg-Essen, Essen, Germany, Essen, Germany.
ORCID-Profile: Christoph Schramm
Zitieren
APA
Schramm, C., Sapuk, A., Hoyer, D., Radünz, S., & Schmidt, H. (2024). Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study. Zeitschrift für Gastroenterologie, 62(01), 37-42. https://doi.org/10.1055/a-2207-5519
Vancouver
Schramm C, Sapuk A, Hoyer D, Radünz S, Schmidt H. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study. Zeitschrift für Gastroenterologie. 2024;62(01):37-42. doi:10.1055/a-2207-5519
BibTeX
@article{Schramm2024,
author = {Schramm, Christoph and Sapuk, Ayaz and Hoyer, Dieter and Radünz, Sonia and Schmidt, Hartmut},
title = {Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {01},
pages = {37--42},
doi = {10.1055/a-2207-5519}
}
EUVIMED